These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8054465)

  • 1. Prolonged oral contraceptive therapy in a woman with an antithrombin III abnormality involving heparin binding (type IIc) without thromboembolic complications.
    Girolami A; Zanardi S; Simioni P; Tormene D
    Blood Coagul Fibrinolysis; 1994 Apr; 5(2):313-4. PubMed ID: 8054465
    [No Abstract]   [Full Text] [Related]  

  • 2. Antithrombin Nagasaki (Ser 116 to Pro): a rare antithrombin variant with abnormal heparin binding presenting during pregnancy.
    O'Ddonnell JS; Hinkson L; McCarthy A; Manning R; Khan A; Laffan MA
    Blood Coagul Fibrinolysis; 2006 Apr; 17(3):217-20. PubMed ID: 16575261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
    Jørgensen M; Petersen LC; Thorsen S
    J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombin III deficiency, deep venous thrombosis, and oral contraceptive use.
    Werner MJ
    J Adolesc Health; 1995 Sep; 17(3):189-92. PubMed ID: 8519788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homozygous variant of antithrombin with lack of affinity for heparin: management of severe thrombotic complications associated with intrauterine fetal demise.
    Bauters A; Zawadzki C; Bura A; Théry C; Watel A; Subtil D; Aiach M; Emmerich J; Jude B
    Blood Coagul Fibrinolysis; 1996 Oct; 7(7):705-10. PubMed ID: 8958394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombin III Kumamoto II; a single mutation at Arg393-His increased the affinity of antithrombin III for heparin.
    Okajima K; Abe H; Wagatsuma M; Okabe H; Takatsuki K
    Am J Hematol; 1995 Jan; 48(1):12-8. PubMed ID: 7832187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptives and surgery: reduced antithrombin and antifactor Xa levels without postoperative venous thrombosis in low-risk patients.
    Gallus AS; Chooi CC; Konetschnik F; Goodall KT
    Thromb Res; 1984 Sep; 35(5):513-26. PubMed ID: 6484897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surveillance of women taking oral contraceptives by determination of antithrombin III].
    Benoit MO; Raichvarg D; Caillens H; Neau C
    Nouv Presse Med; 1979 Feb; 8(7):528-9. PubMed ID: 461171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombin Padua. I: Impaired heparin binding caused by an Arg47 to his (CGT to CAT) substitution.
    Caso R; Lane DA; Thompson E; Zangouras D; Panico M; Morris H; Olds RJ; Thein SL; Girolami A
    Thromb Res; 1990 Apr; 58(2):185-90. PubMed ID: 2349545
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect or oral contraceptives on antithrombin III.
    McEntee MP; Jesty J; Hultin MB
    Thromb Res; 1981 Oct 1-15; 24(1-2):13-20. PubMed ID: 6800055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of an abnormal antithrombin (Milano 2) with defective thrombin binding.
    Tripodi A; Krachmalnicoff A; Mannucci PM
    Thromb Haemost; 1986 Dec; 56(3):349-52. PubMed ID: 3563966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological coagulation inhibitors (protein S, protein C and antithrombin III) in severe preeclamptic states and in users of oral contraceptives.
    Gilabert J; Fernandez JA; España F; Aznar J; Estelles A
    Thromb Res; 1988 Feb; 49(3):319-29. PubMed ID: 2966452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombin Glasgow, 393 Arg to His: a P1 reactive site variant with increased heparin affinity but no thrombin inhibitory activity.
    Owen MC; Beresford CH; Carrell RW
    FEBS Lett; 1988 Apr; 231(2):317-20. PubMed ID: 3360140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A preliminary report on the relationship between serum anti-thrombin III concentration in pre- and post-operative patients and in women on oral contraceptives.
    Ton SH; Lopez CG; Thiruselvam A; Lyou YT
    Med J Malaysia; 1981 Dec; 36(4):212-4. PubMed ID: 7334955
    [No Abstract]   [Full Text] [Related]  

  • 15. New carbohydrate site in mutant antithrombin (7 Ile----Asn) with decreased heparin affinity.
    Brennan SO; Borg JY; George PM; Soria C; Soria J; Caen J; Carrell RW
    FEBS Lett; 1988 Sep; 237(1-2):118-22. PubMed ID: 3169232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The physiological inhibitors of blood coagulation. 1. Antithrombin III (AT III)].
    Kase F; Pospísil J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(3):337-49. PubMed ID: 6194066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombin 3 depression and thrombin generation acceleration in women taking oral contraceptives.
    Von Kaulla E; Droegemueller W; Aoki N; Von Kaulla KN
    Am J Obstet Gynecol; 1971 Mar; 109(6):868-73. PubMed ID: 5552623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new familial variant of antithrombin III: 'antithrombin III Paris'.
    Wolf M; Boyer C; Lavergne JM; Larrieu MJ
    Br J Haematol; 1982 Jun; 51(2):285-95. PubMed ID: 7082587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Abnormal antithrombin III: abnormalities of heparin or protease binding domain].
    Sakuragawa N; Niiya K; Takahashi K; Hayashi T; Oguma Y; Saitoh S
    Rinsho Byori; 1993 May; 41(5):492-505. PubMed ID: 8350512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of the activity of antithrombin-III in latent cholestasis. (A clinico-pharmacological study of the relationship between antithrombin-III activity and steroid cholestasis).
    Horváth T; Nagy I; Gógl A
    Acta Med Acad Sci Hung; 1978; 35(2):105-13. PubMed ID: 742337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.